<DOC>
	<DOCNO>NCT01290341</DOCNO>
	<brief_summary>This 6-week , double-blind , randomize , placebo-controlled , multicenter , parallel group Phase 3 study NAFT-600 apply day 2 week compare vehicle ( placebo ) treatment tinea pedis .</brief_summary>
	<brief_title>Evaluation Efficacy Safety NAFT-600 Subjects With Tinea Pedis</brief_title>
	<detailed_description>This study open male non-pregnant female , 12 year age , clinical sign symptom tinea pedis consist least moderate erythema , moderate scaling , mild pruritus , positive screening KOH , positive culture.Subjects evaluate Day 1 ( baseline ) , Week 2 , Week 4 , Week 6 ( follow-up ) . Adverse event , concomitant medication , study drug compliance review visit . Efficacy assessment include KOH culture evaluation , clinical signs/symptoms ( erythema , scaling , pruritus ) , Investigator 's Global Assessment .</detailed_description>
	<mesh_term>Tinea</mesh_term>
	<mesh_term>Tinea Pedis</mesh_term>
	<mesh_term>Naftifine</mesh_term>
	<criteria>Males nonpregnant female , â‰¥12 year age , race sex . Females childbearing potential must negative urine pregnancy test . For minor ( less 18 year ) , parent/legal guardian must complete informed consent process AND subject must complete assent process sign appropriate form ( age appropriate ) . Presence interdigital interdigital moccasin type tinea pedis one foot characterize clinical evidence tinea infection ( least moderate erythema , moderate scaling mild pruritus ) base sign symptom affect area ( ) . Subjects lifethreatening condition ( ex . autoimmune deficiency syndrome , cancer , unstable angina myocardial infarction ) within last 6 month . Subjects abnormal finding physical laboratory consider investigator clinically important indicative condition might complicate interpretation study result . Subjects know hypersensitivity study drug component . Subjects recent history currently know abuse alcohol drug . Uncontrolled diabetes mellitus . Hemodialysis chronic ambulatory peritoneal dialysis therapy . Current diagnosis immunocompromising condition . Foot psoriasis , corn and/or callus involve web space , atopic contact dermatitis . Severe dermatophytoses , onychomycosis ( evaluated foot ) , mucocutaneous candidiasis bacterial skin infection . Extremely severe tinea pedis ( incapacitate ) . Female subject pregnant lactating , use agree use acceptable form contraception study , intend become pregnant study .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>fungal infection</keyword>
	<keyword>athlete foot</keyword>
</DOC>